Cargando…

Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation

BACKGROUNDS: Zero-events studies frequently occur in systematic reviews of adverse events, which consist of an important source of evidence. We aimed to examine how evidence of zero-events studies was utilized in the meta-analyses of systematic reviews of adverse events. METHODS: We conducted a surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chang, Zhou, Xiaoqin, Zorzela, Liliane, Ju, Ke, Furuya-Kanamori, Luis, Lin, Lifeng, Lu, Cuncun, Musa, Omran A. H., Vohra, Sunita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204528/
https://www.ncbi.nlm.nih.gov/pubmed/34126999
http://dx.doi.org/10.1186/s12916-021-02008-2
_version_ 1783708356475617280
author Xu, Chang
Zhou, Xiaoqin
Zorzela, Liliane
Ju, Ke
Furuya-Kanamori, Luis
Lin, Lifeng
Lu, Cuncun
Musa, Omran A. H.
Vohra, Sunita
author_facet Xu, Chang
Zhou, Xiaoqin
Zorzela, Liliane
Ju, Ke
Furuya-Kanamori, Luis
Lin, Lifeng
Lu, Cuncun
Musa, Omran A. H.
Vohra, Sunita
author_sort Xu, Chang
collection PubMed
description BACKGROUNDS: Zero-events studies frequently occur in systematic reviews of adverse events, which consist of an important source of evidence. We aimed to examine how evidence of zero-events studies was utilized in the meta-analyses of systematic reviews of adverse events. METHODS: We conducted a survey of systematic reviews published in two periods: January 1, 2015, to January 1, 2020, and January 1, 2008, to April 25, 2011. Databases were searched for systematic reviews that conducted at least one meta-analysis of any healthcare intervention and used adverse events as the exclusive outcome. An adverse event was defined as any untoward medical occurrence in a patient or subject in healthcare practice. We summarized the frequency of occurrence of zero-events studies in eligible systematic reviews and how these studies were dealt with in the meta-analyses of these systematic reviews. RESULTS: We included 640 eligible systematic reviews. There were 406 (63.45%) systematic reviews involving zero-events studies in their meta-analyses, among which 389 (95.11%) involved single-arm-zero-events studies and 223 (54.93%) involved double-arm-zero-events studies. The majority (98.71%) of these systematic reviews incorporated single-arm-zero-events studies into the meta-analyses. On the other hand, the majority (76.23%) of them excluded double-arm-zero-events studies from the meta-analyses, of which the majority (87.06%) did not discuss the potential impact of excluding such studies. Systematic reviews published at present (2015-2020) tended to incorporate zero-events studies in meta-analyses than those published in the past (2008-2011), but the difference was not significant (proportion difference=−0.09, 95% CI −0.21 to 0.03, p = 0.12). CONCLUSION: Systematic review authors routinely treated studies with zero-events in both arms as “non-informative” carriers and excluded them from their reviews. Whether studies with no events are “informative” or not largely depends on the methods and assumptions applied, thus sensitivity analyses using different methods should be considered in future meta-analyses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-02008-2.
format Online
Article
Text
id pubmed-8204528
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82045282021-06-16 Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation Xu, Chang Zhou, Xiaoqin Zorzela, Liliane Ju, Ke Furuya-Kanamori, Luis Lin, Lifeng Lu, Cuncun Musa, Omran A. H. Vohra, Sunita BMC Med Research Article BACKGROUNDS: Zero-events studies frequently occur in systematic reviews of adverse events, which consist of an important source of evidence. We aimed to examine how evidence of zero-events studies was utilized in the meta-analyses of systematic reviews of adverse events. METHODS: We conducted a survey of systematic reviews published in two periods: January 1, 2015, to January 1, 2020, and January 1, 2008, to April 25, 2011. Databases were searched for systematic reviews that conducted at least one meta-analysis of any healthcare intervention and used adverse events as the exclusive outcome. An adverse event was defined as any untoward medical occurrence in a patient or subject in healthcare practice. We summarized the frequency of occurrence of zero-events studies in eligible systematic reviews and how these studies were dealt with in the meta-analyses of these systematic reviews. RESULTS: We included 640 eligible systematic reviews. There were 406 (63.45%) systematic reviews involving zero-events studies in their meta-analyses, among which 389 (95.11%) involved single-arm-zero-events studies and 223 (54.93%) involved double-arm-zero-events studies. The majority (98.71%) of these systematic reviews incorporated single-arm-zero-events studies into the meta-analyses. On the other hand, the majority (76.23%) of them excluded double-arm-zero-events studies from the meta-analyses, of which the majority (87.06%) did not discuss the potential impact of excluding such studies. Systematic reviews published at present (2015-2020) tended to incorporate zero-events studies in meta-analyses than those published in the past (2008-2011), but the difference was not significant (proportion difference=−0.09, 95% CI −0.21 to 0.03, p = 0.12). CONCLUSION: Systematic review authors routinely treated studies with zero-events in both arms as “non-informative” carriers and excluded them from their reviews. Whether studies with no events are “informative” or not largely depends on the methods and assumptions applied, thus sensitivity analyses using different methods should be considered in future meta-analyses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-02008-2. BioMed Central 2021-06-15 /pmc/articles/PMC8204528/ /pubmed/34126999 http://dx.doi.org/10.1186/s12916-021-02008-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Xu, Chang
Zhou, Xiaoqin
Zorzela, Liliane
Ju, Ke
Furuya-Kanamori, Luis
Lin, Lifeng
Lu, Cuncun
Musa, Omran A. H.
Vohra, Sunita
Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation
title Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation
title_full Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation
title_fullStr Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation
title_full_unstemmed Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation
title_short Utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation
title_sort utilization of the evidence from studies with no events in meta-analyses of adverse events: an empirical investigation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204528/
https://www.ncbi.nlm.nih.gov/pubmed/34126999
http://dx.doi.org/10.1186/s12916-021-02008-2
work_keys_str_mv AT xuchang utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation
AT zhouxiaoqin utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation
AT zorzelaliliane utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation
AT juke utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation
AT furuyakanamoriluis utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation
AT linlifeng utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation
AT lucuncun utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation
AT musaomranah utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation
AT vohrasunita utilizationoftheevidencefromstudieswithnoeventsinmetaanalysesofadverseeventsanempiricalinvestigation